Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Grant US-11851434-B2 United States of America 26 Dec 2023
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-11648243-B2 United States of America 16 May 2023
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors Grant US-11603374-B2 United States of America 14 Mar 2023
Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors Grant US-11524963-B2 United States of America 13 Dec 2022
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a… Grant US-11484535-B2 United States of America 01 Nov 2022
Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors Grant US-11472802-B2 United States of America 18 Oct 2022
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Grant US-11267818-B2 United States of America 08 Mar 2022
Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazol… Grant US-11214571-B2 United States of America 04 Jan 2022
Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors Grant US-11168090-B2 United States of America 09 Nov 2021
ALK and NTRK1 fusion molecules and uses thereof Grant US-11098368-B2 United States of America 24 Aug 2021
Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof Grant US-11091486-B2 United States of America 17 Aug 2021
Macrocyclic compounds as ROS1 kinase inhibitors Grant US-10966985-B2 United States of America 06 Apr 2021
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10953005-B1 United States of America 23 Mar 2021
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10907215-B2 United States of America 02 Feb 2021
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10881652-B2 United States of America 05 Jan 2021
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]py… Grant US-10813936-B2 United States of America 27 Oct 2020
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]py… Grant US-10799505-B2 United States of America 13 Oct 2020
NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF Application US-20200299775-A1 United States of America 24 Sep 2020
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds Grant US-10774085-B2 United States of America 15 Sep 2020
Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors Grant US-10758542-B2 United States of America 01 Sep 2020
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10724102-B2 United States of America 28 Jul 2020
Macrocylic compounds as ROS1 kinase inhibitors Grant US-10688100-B2 United States of America 23 Jun 2020
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a… Grant US-10668072-B2 United States of America 02 Jun 2020
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10655186-B2 United States of America 19 May 2020
Macrocyclic compounds as TRK kinase inhibitors Grant US-10647730-B2 United States of America 12 May 2020
Method of treatment using substituted imidazo[1,2b]pyridazine compounds Grant US-10590139-B2 United States of America 17 Mar 2020
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10555944-B2 United States of America 11 Feb 2020
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10441581-B2 United States of America 15 Oct 2019
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10378068-B2 United States of America 13 Aug 2019
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10370727-B2 United States of America 06 Aug 2019
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]py… Grant US-10285993-B2 United States of America 14 May 2019
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Grant US-10251889-B2 United States of America 09 Apr 2019
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]py… Grant US-10172861-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10174027-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10174028-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10172851-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10172845-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10144734-B2 United States of America 04 Dec 2018
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10137124-B2 United States of America 27 Nov 2018
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10138243-B2 United States of America 27 Nov 2018
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A… Grant US-10137127-B2 United States of America 27 Nov 2018
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10112942-B2 United States of America 30 Oct 2018
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Grant US-10047097-B2 United States of America 14 Aug 2018
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10023570-B2 United States of America 17 Jul 2018
Method of treatment using substituted imidazo[1,2b]pyridazine compounds Grant US-10011604-B2 United States of America 03 Jul 2018
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Grant US-10005783-B2 United States of America 26 Jun 2018
ALK and NTRK1 fusion molecules and uses thereof Grant US-10000814-B2 United States of America 19 Jun 2018
Macrocyclic compounds as TRK kinase inhibitors Grant US-9902741-B2 United States of America 27 Feb 2018
Macrocyclic compounds as TRK kinase inhibitors Grant US-9840519-B2 United States of America 12 Dec 2017
Method of treatment using substituted imidazo[1,2b]pyridazine compounds Grant US-9795611-B2 United States of America 24 Oct 2017
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Grant US-9796724-B2 United States of America 24 Oct 2017
Method of treatment using substituted imidazo[1,2b]pyridazine compounds Grant US-9796723-B2 United States of America 24 Oct 2017
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Grant US-9782415-B2 United States of America 10 Oct 2017
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]py… Grant US-9782414-B2 United States of America 10 Oct 2017
Furo-3-carboxamide derivatives and methods of use Application US-9777020-B2 United States of America 03 Oct 2017
Macrocyclic compounds as Trk kinase inhibitors Grant US-9750744-B2 United States of America 05 Sep 2017
Macrocyclic compounds as Trk kinase inhibitors Grant US-9718822-B2 United States of America 01 Aug 2017
DIHYDRONAPHTHO[2,3-b]BENZOFURAN DERIVATIVE Application WO-2017073706-A1 World Intellectual Property Organisation (WIPO) 04 May 2017
NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF Application US-20150073036-A1 United States of America 12 Mar 2015
9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine… Grant US-8486966-B2 United States of America 16 Jul 2013
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors Grant US-8114989-B2 United States of America 14 Feb 2012
4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the… Grant US-8088784-B2 United States of America 03 Jan 2012